Internal Medicine, Hematology & Oncology · Middletown, NY
NPI
1295126670
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
707 E Main St
Middletown, NY, 10940
Phone (845) 333-7575
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
118,602 services
Medicare patients, 2024
534
Average age 74
Drug cost, 2024
$3.2M
801 prescriptions
Company payments, 2025
$316
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Varun Modi was code J1439 (injection, ferric carboxymaltose, 1 mg), 32,250 times for 24 patients. In total Varun Modi billed 118,602 services in 169 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 32,250 | 24 | $0.88 | $28K |
| J1756 Injection, iron sucrose, 1 mg | Office | 23,600 | 32 | $0.17 | $4,038 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,152 | 48 | $0.09 | $192 |
| 36415 Venipuncture Blood Collection | Office | 1,612 | 377 | $8.64 | $14K |
| 85025 Blood Count | Office | 1,506 | 379 | $7.60 | $11K |
| 88185 Surgical Pathology Examination | Office | 1,472 | 63 | $20.72 | $30K |
| 80053 Clinical Chemistry | Office | 1,097 | 330 | $10.31 | $11K |
| 83521 Immunoassay | Office | 532 | 170 | $16.74 | $8,907 |
| 83735 Clinical Chemistry | Office | 495 | 119 | $6.55 | $3,241 |
| 84100 Clinical Chemistry | Office | 495 | 121 | $4.64 | $2,297 |
| 99214 Office E&M - Established | Office | 468 | 214 | $103.88 | $49K |
| 82784 Immunoassay | Office | 447 | 127 | $9.06 | $4,050 |
| 99213 Office E&M - Established | Office | 435 | 239 | $74.66 | $32K |
| 99232 Hospital E&M - Subsequent | Facility | 408 | 141 | $65.89 | $27K |
| 99233 Hospital E&M - Subsequent | Facility | 390 | 107 | $99.02 | $39K |
By year: 2022 $117K for 1,137 services; 2023 $418K for 27,018 services; 2024 $1.5M for 118,602 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,612 | 377 | $8.64 | $14K |
| 85025 Blood Count | 1,506 | 379 | $7.60 | $11K |
| 88185 Surgical Pathology Examination | 1,472 | 63 | $20.72 | $30K |
| 80053 Clinical Chemistry | 1,097 | 330 | $10.31 | $11K |
| 83521 Immunoassay | 532 | 170 | $16.74 | $8,907 |
| 84100 Clinical Chemistry | 495 | 121 | $4.64 | $2,297 |
| 83735 Clinical Chemistry | 495 | 119 | $6.55 | $3,241 |
| 82784 Immunoassay | 447 | 127 | $9.06 | $4,050 |
| 82728 Clinical Chemistry | 314 | 190 | $13.20 | $4,143 |
| 83540 Clinical Chemistry | 312 | 189 | $6.26 | $1,954 |
Medicare prescription drug claims, 2024
In 2024, the drug Varun Modi prescribed most often to Medicare patients was Eliquis (Apixaban), with 100 prescriptions and refills. In total Varun Modi wrote 801 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 100 | 126 | 33 | $72K |
| Anastrozole Generic | 70 | 168 | 28 | $1,411 |
| Akynzeo Fosnetupitant/Palonosetron | 69 | 69 | 22 | $71K |
| Xtandi Enzalutamide | 41 | 41 | Under 11 | $571K |
| Neulasta Onpro Pegfilgrastim | 35 | 35 | 12 | $259K |
| Ondansetron Odt Ondansetron | 29 | 29 | 20 | $516 |
| Neulasta Pegfilgrastim | 25 | 25 | Under 11 | $236K |
| Jakafi Ruxolitinib Phosphate | 21 | 21 | Under 11 | $264K |
| Prednisone Generic | 20 | 20 | Under 11 | $139 |
| Xarelto Rivaroxaban | 19 | 37 | Under 11 | $20K |
| Lupron Depot Leuprolide Acetate | 18 | 54 | Under 11 | $101K |
| Imfinzi Durvalumab | 17 | 17 | Under 11 | $212K |
| Prochlorperazine Maleate Generic | 17 | 17 | 12 | $196 |
| Potassium Chloride Generic | 16 | 16 | Under 11 | $59.21 |
| Gemcitabine Hcl Generic | 15 | 15 | Under 11 | $3,979 |
Brand drugs: 476 claims; generic drugs: 325 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Varun Modi $316 ($316 in general payments such as food, travel and fees) from 9 companies. The largest payer was Pfizer Inc. with $115.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 6 | $115 |
| Array Biopharma Inc PFE | 4 | $45.14 |
| Genzyme Corporation SNY | 1 | $40.59 |
| Tempus AI, Inc TEM | 1 | $26.3 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $23.29 |
| Sobi, Inc SOBI.ST | 1 | $19.85 |
| Menarini Silicon Biosystems, Inc. | 1 | $16.32 |
| Celgene Corporation BMY | 1 | $15.17 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $14.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.